Endo Shares Outstanding 2006-2019 | ENDP

Endo shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Endo Annual Shares Outstanding
(Millions of Shares)
2018 224
2017 223
2016 223
2015 197
2014 157
2013 120
2012 116
2011 121
2010 118
2009 118
2008 124
2007 135
2006 134
2005 133
Endo Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 227
Q2 2019 226
Q1 2019 225
Q4 2018 224
Q3 2018 224
Q2 2018 224
Q1 2018 224
Q4 2017 223
Q3 2017 223
Q2 2017 223
Q1 2017 223
Q4 2016 223
Q3 2016 223
Q2 2016 223
Q1 2016 222
Q4 2015 197
Q3 2015 209
Q2 2015 185
Q1 2015 177
Q4 2014 157
Q3 2014 159
Q2 2014 163
Q1 2014 128
Q4 2013 120
Q3 2013 120
Q2 2013 117
Q1 2013 113
Q4 2012 116
Q3 2012 120
Q2 2012 121
Q1 2012 117
Q4 2011 121
Q3 2011 121
Q2 2011 123
Q1 2011 121
Q4 2010 118
Q3 2010 117
Q2 2010 117
Q1 2010 118
Q4 2009 118
Q3 2009 118
Q2 2009 117
Q1 2009 117
Q4 2008 124
Q3 2008 120
Q2 2008 124
Q1 2008 135
Q4 2007 135
Q3 2007 135
Q2 2007 135
Q1 2007 134
Q4 2006 134
Q3 2006 134
Q2 2006 134
Q1 2006 134
Q4 2005 133
Q3 2005 134
Q2 2005 133
Q1 2005 133
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.943B $2.947B
Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.374B 9.86
Zoetis (ZTS) United States $55.370B 33.12
Astellas Pharma (ALPMY) Japan $31.354B 15.66
Eisai (ESALY) Japan $18.833B 36.31
Merck (MKGAF) Germany $15.199B 20.74
Grifols, S.A (GRFS) Spain $14.885B 18.99
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.118B 477.70
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.129B 16.46
Jazz Pharmaceuticals (JAZZ) Ireland $7.571B 9.67
Sage Therapeutics (SAGE) United States $7.295B 0.00
Catalent (CTLT) United States $7.185B 29.23
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
STADA ARZNEIMI (STDAF) Germany $5.375B 0.00
Hypermarcas (HYPMY) Brazil $5.178B 18.61
Arrowhead Pharmaceuticals (ARWR) United States $4.598B 105.43
United Therapeutics (UTHR) United States $3.929B 0.00
Nektar Therapeutics (NKTR) United States $3.418B 0.00
FibroGen (FGEN) United States $3.052B 89.69
Evotec AG (EVTCY) Germany $3.051B 49.93
Taro Pharmaceutical Industries (TARO) Israel $2.937B 10.73
PTC Therapeutics (PTCT) United States $2.633B 0.00
Portola Pharmaceuticals (PTLA) United States $2.091B 0.00
Xencor (XNCR) United States $2.040B 62.00
Zogenix (ZGNX) United States $2.005B 0.00
Tilray (TLRY) Canada $1.986B 0.00
Corcept Therapeutics (CORT) United States $1.888B 22.94
Heron Therapeutics (HRTX) United States $1.877B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.819B 58.00
Pacira Pharmaceuticals (PCRX) United States $1.777B 52.57
USANA Health Sciences (USNA) United States $1.561B 16.66
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.221B 20.14
Radius Health (RDUS) United States $1.095B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
Karyopharm Therapeutics (KPTI) United States $0.964B 0.00
ArQule (ARQL) United States $0.945B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.907B 0.00
Aerie Pharmaceuticals (AERI) United States $0.844B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.811B 5.53
TherapeuticsMD (TXMD) United States $0.746B 0.00
Organogenesis Holdings (ORGO) United States $0.740B 0.00
Collegium Pharmaceutical (COLL) United States $0.613B 0.00
Flexion Therapeutics (FLXN) United States $0.610B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Translate Bio (TBIO) United States $0.550B 0.00
ChemoCentryx (CCXI) United States $0.508B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.484B 58.75
Aptorum Group (APM) Hong Kong, SAR China $0.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.413B 0.00
Dermira (DERM) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.406B 9.28
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.76
Ardelyx (ARDX) United States $0.387B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 0.00
Akebia Therapeutics (AKBA) United States $0.383B 0.00
Indivior (INVVY) United States $0.378B 1.37
Lannett Co Inc (LCI) United States $0.376B 4.37
Recro Pharma (REPH) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
DURECT (DRRX) United States $0.367B 0.00
Harpoon Therapeutics (HARP) United States $0.325B 0.00
GlycoMimetics (GLYC) United States $0.282B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.278B 0.00
Molecular Templates (MTEM) United States $0.259B 0.00
Xeris Pharmaceuticals (XERS) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.195B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 31.83
Calithera Biosciences (CALA) United States $0.181B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.175B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 2.34
La Jolla Pharmaceutical (LJPC) United States $0.164B 0.00
Concert Pharmaceuticals (CNCE) United States $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
CV Sciences (CVSI) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
MEI Pharma (MEIP) United States $0.133B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.129B 0.00
Ocular Therapeutix (OCUL) United States $0.128B 0.00
CannTrust Holdings (CTST) Canada $0.126B 0.00
IMV INC (IMV) Canada $0.122B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.093B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Majesco Entertainment (PTE) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.64
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Generex Biotechnology (GNBT) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.064B 15.96
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Novan (NOVN) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.053B 0.00
Nivalis Therapeutics (ALPN) United States $0.051B 0.00
Capnia (SLNO) United States $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Mast Therapeutics (SVRA) United States $0.029B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 16.42
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00